Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2024-10-01

Clinical Trial Update: RCT Glargine vs NPH for Treatment of DM in Pregnancy [Phase 3]

View source ↗

Summary

This Phase 3 randomized trial compares insulin glargine to NPH insulin for diabetes management in pregnancy and is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Insulin Glargine (insulin glargine)
  • insulin NPH (insulin NPH)

Snippet

Sponsor: Loyola University | Conditions: Diabetes Mellitus in Pregnancy, Type 2 Diabetes Mellitus (T2DM) | Phase 3 | Status: RECRUITING